The link between PAQR6 and hypoxia-induced factors such as HIF1A suggests that it may act downstream of hypoxia-regulated pathways, integrating immune suppression and angiogenesis in the tumor microenvironment (34, 35). Here, PAQR6 is linked to neoplasm.